Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
NHS updates outdated IP rules in bid to revive UK life sciences
Europe
The country’s public health service has replaced its IP framework with a nine-step plan, as the government tries to reposition the UK as a global life sciences leader.   20 November 2025
MSD wins full sweep in world’s best-selling drug clash
Americas
A PTAB dispute over $29.5bn drug reaches a dramatic conclusion, at a critical time ahead of the drug's US patent expiration.   20 November 2025
Report reveals surge of AI adoption in IP but lawyers remain cautious
Big Pharma
A new report from Clarivate highlights a jump in the tech’s adoption among IP professionals over the past two years, as well as concerns over governance.   20 November 2025
Americas
President-elect Deborah Hampton says she is looking forward to advancing the association’s advocacy work in the new year, and implementing its 2026–2029 plan.   20 November 2025
Americas
The court rules that Duke University and Allergan’s patent lacked sufficient written description, in the wake of stricter post-Amgen Section 112 standards.   19 November 2025
Careers
The combination will create a firm with 3,000 lawyers across 52 offices—but a dive into its combined IP practice shows a heavy weighting in the US.   18 November 2025
Americas
An EUIPO appeals board sided with the French pharma company’s vaccine division in a dispute with an India-based biotech company over Sanofi’s ‘Covaxis’ mark.   18 November 2025
Careers
With “deep connections” in the US and Asia and life sciences patents in his name, the new partner joins the firm at a time of IP practice expansion.   18 November 2025
Americas
A federal jury finds Apple infringed Masimo’s pulse oximetry patent, while the ITC has opened a new proceeding to review Apple's redesigned smartwatch.   17 November 2025
Europe
In-house counsel from AstraZeneca, BAT and Novartis say that investing in AI now will pay off in time saved, but warn that tools remain prone to ‘confident’ errors, writes Marisa Woutersen.   14 November 2025